ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2024, Vol. 33 ›› Issue (3): 233-238.DOI: 10.3969/j.issn.1006-298X.2024.03.006

• 论著 • 上一篇    下一篇

高流量内瘘对维持性血液透析患者心脏功能和远期预后的影响

  

  • 出版日期:2024-06-28 发布日期:2024-06-26

High-flow arteriovenous fistula on cardiac function in maintenance hemodialysis patients

  • Online:2024-06-28 Published:2024-06-26

摘要: 目的:分析高流量内瘘的维持性血液透析(MHD)患者临床特点以及心脏结构和功能的改变,评估高流量内瘘对MHD患者死亡和心血管事件的影响。
方法:纳入2022年2月至5月在南京医科大学第二附属医院肾脏病中心行MHD的患者。内瘘血流量≥1 500 mL/min定义为高流量内瘘,将患者分为高流量内瘘组和非高流量内瘘组。分析两组患者临床特征和心脏超声参数的特点,并比较心血管事件和死亡的发生风险。
结果:共341例MHD患者纳入研究,其中男性210例(61.6%),平均年龄57.3±12.3岁,中位透析龄78.7(33.0~151.1)月,内瘘血流量≥1 500 mL/min的患者为138例(40.5%)。高流量内瘘组患者右房横径更大(P=0.005),主肺动脉直径更大(P=0.007),主肺动脉流速更快(P=0.042),心脏瓣膜钙化的比例更高(P=0.028),内瘘血流量/心输出量(CO)的比值更高(P<0.001),其余心脏超声指标在两组中无差异。内瘘位于上臂(OR=3.503,95%CI 1.702~7.209,P<0.001)、内瘘建立时较高舒张压(OR=1.045,95%CI 1.018~1.072,P<0.001)是高流量内瘘的独立影响因素。两组患者发生心血管事件的风险无统计学差异,但高流量内瘘组患者死亡风险更高(P=0.013)。
结论:高流量内瘘的MHD患者全因死亡的风险增加,内瘘位于上臂和内瘘建立时舒张压高是内瘘高流量的独立影响因素。


关键词: 维持性血液透析, 动静脉内瘘, 高流量内瘘, 心脏超声检查

Abstract: Objective:To analyze the clinical characteristics of maintenance hemodialysis (MHD) patients with high-flow arteriovenous fistulas,alongside the alterations in cardiac structure and function,to evaluate the influence of high-flow arteriovenous fistulas on mortality and cardiovascular events in MHD patients.
Methodology:This study included patients undergoing hemodialysis at department of nephrology,the second affiliated hospital of Nanjing Medical University between March and May 2022. High-flow arteriovenous fistula was defined as fistula blood flow≥1 500 mL/min. Patients were divided into two groups,high-flow arteriovenous fistula,and non-high-flow arteriovenous fistula. The study analyzed baseline clinical characteristics and echocardiographic parameters of both groups,comparing the risk of cardiovascular events and mortality between the two groups.
Results:The study included 341 MHD patients of which 210 (61.6%) were male. The mean age was 57.3 ± 12.3 years,and the median duration of dialysis was 78.7 (33.0~151.1) months. Among the patients,138 (40.5%) had an internal fistula blood flow of≥1 500 mL/min. In the high-flow arteriovenous fistula group,patients had a larger right atrial diameter (P=0.005),a larger main pulmonary artery diameter (P=0.007),a faster main pulmonary artery flow velocity (P=0.042),a higher proportion of heart valve calcification (P=0.028),and a higher ratio of arteriovenous fistula flow to cardiac output (P<0.001). Other echocardiographic parameters did not differ between the two groups. The location of the fistula in the upper arm (OR=3.503,95%CI 1.702~7.209,P<0.001) and higher diastolic blood pressure at fistula creation (OR=1.045,95%CI 1.018~1.072,P<0.001) were independent factors influencing high-flow arteriovenous fistulas. The risk of cardiovascular events did not differ between the two groups (P=0.369),but the high-flow arteriovenous fistula group had a higher risk of mortality (P=0.013).
Conclusion:MHD patients with high-flow arteriovenous fistulas did experience an increased risk of all-cause mortality. The independent factors associated with high-flow arteriovenous fistulas included the location of the fistula in the upper arm and higher diastolic blood pressure at fistula creation.


Key words: aintenance hemodialysis, arteriovenous fistula, high-flow arteriovenous fistula, echocardiography